Obesity Research · Vol. 2, No. 2 · 2015 · pp. 73–80 · e-ISSN 2377-8385

Daily Calcium Intervention for a Weight-Loss Program Resulted in More Significant Decreases in Body Weight, BMI, Body Fat Mass, and Body Fat Percentage

Yen-Ling Chen, Yi-Chun Chen, Jung-Su Chang, Jo Chun Lin, Yi-Wen Chien

Department of Internal Medicine, Division of Metabolism and Endocrinology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan, ROCTaiwan
School of Nutrition and Health Sciences, Taipei Medical University, Taipei, Taiwan, ROCTaiwan

DOI: https://doi.org/10.17140/oroj-2-112 · Published 2015-08-19 · Licence: https://creativecommons.org/licenses/by/4.0 · © 2015 The Author(s)

Abstract

The purpose of this study was to assess of calcium intervention on the effectiveness of a weight-loss program for obese people. All subjects had an initial BMI (body mass index) >24 kg/m2 and low calcium diet (<500 mg/d). Forty-two healthy overweight or obese people were randomly and equally divided into two groups: a Hi-Ca group (female: 16, male: 5) and a control group (female: 16, male: 5). In the Hi-Ca group, we provided two bottles of Hi-Ca drinks per day and a low energy diet (energy: 1200 kcal, carbohydrate: 55%, fat: 25%, protein: 20%) for eight weeks. In the control group, we only provided the low energy diet for eight weeks. We measured three-day food records, anthropometric and blood biochemical data at Weeks 0 and 8. Calcium intake was 964.5±75.5 mg in the Hi-Ca group and was 353.7±96.6 mg in the control group (p<0.05). After eight weeks, results showed the loss of body weight (-6.9±3.3 kg, p<0.05), BMI (-2.7±1.1 kg/m2 , p<0.01), body fat mass (-5.7±2.7 kg, p<0.05), body fat percentage (-4.4±1.9 %, p<0.002) and TC/HDL-C (-0.4±0.6, p<0.05) in the Hi-Ca group were significantly different from those of the control group at eight weeks. In the lipid profile, serum cholesterol, triglycerides and LDL-C concentration were significantly decreased compared with Week 0. The serum PTH (parathyroid hormone) levels in the Hi-Ca group were significantly lower compared with baseline (-5.3±10.4 pg/mL, p<0.05), which showed that the concentration of PTH and calcium intake are negatively correlated, and indicate that a highcalcium low-energy diet resulted in more significant decreases in body weight, BMI, body fat mass, and body fat percentage. Therefore, a high calcium diet increases the effectiveness of an energy-restricted diet for weight loss in overweight people.

Keywords: Obesity; Energy restricted diet; Weight loss; Calcium; Parathyroid hormone (PTH); Obesity; Energy restricted diet; Weight loss; Calcium; Parathyroid hormone (PTH)

Introduction

1-3 chronic disease, such as heart disease, cancer, stroke and diabe- 4-7 (CVD) and diabetes mellitus. To study this relationship, we assessed the impact of a dietary calcium intervention on the effectiveness of a weight loss program for obese people.

dairy products may contribute to shifting the energy balance, and thus play a role in weight reg-

5,9-12 ulation. It has recently been shown that overweight people with low calcium and dairy consumption were at much greater risk of developing metabolic syndrome over a ten-year followup period than were overweight people who had high calcium and dairy consumption.13 This finding suggests that adequate calcium intake could exert a significant effect on the predisposition to a healthier metabolic profile, similar to that of a macronutrient-balanced diet and regular physical activity.14

Increased dietary calcium without energy restriction is associated with decreased fat mass in both animals and hu- 15,16 mans and thus may play a role in the attenuation of obesity and its related health complications. The inverse association between calcium and body mass was established twenty years ago by McCarron.17 One possible factor to explain the relationship between calcium intake and BMI is the fatty acid binding capacity of calcium. An alternative hypothesis for explaining the anti-obesity effect of calcium links dietary calcium intake, serum 1,25-dihydroxy vitamin D concentration and adipocyte intracellular calcium concentration. A low calcium diet leads to an increase in 1,25-(OH)2-D which in turn stimulates calcium influx into adipocytes, resulting in stimulation of lipogenesis, inhibition of lipolysis and expansion of adipocyte triglyceride stores. Suppressing 1,25-(OH)2-D levels by increasing dietary calcium may consequently be predicted to inhibit adiposity and 10,12,19 promote weight loss Calcium in the form of dairy products may be more effective than elemental calcium, and high concentrations of branched chain amino acids in dairy products are responsible for this effect. The objective of the current study was to investigate the relationship between calcium intake and body composition, body fat distribution and serum lipid profile in overweight or obese subjects.

Materials And Methods

Subjects

This study was proposed and conducted at Taipei Medical University. We recruited a total of 42 volunteer participants prior to the experiment start date. There were no significant differences between those who completed the study and those who did not on any parameters. Baseline participant characteristics are described in Table 1. Subjects were recruited via a flyer advertisement in Taipei Medical University. The subjects had to meet the following criteria: age 18-64 years; Body Mass Index (BMI) higher than 24; calcium consumption <500 mg/day (according to three-day food records); no history of chronic disease, including history of cardiovascular disease, kidney disease, liver disease, endocrine disorders, and diabetes mellitus; women were included only if they were not pregnant or breast-feeding; and no participation in another clinical trial (within six months) was permitted. Sample-size calculations were based on results from a randomized, parallel-design study, we estimated that a sample size of 20 subjects/grout in the current would yield 80% power (2-tailed α=0.05) to detect a similar group difference. At the

gibility, 28 were excluded (26 not meeting inclusion criteria, 2 declined to participate). The Research Ethics Committee, Taipei Medical University, Taiwan, approved the study and all subjects gave written informed consent before their participation.

Characteristics Hi Ca group Control group

male : female 5:16 5:16 Age (years) 43.0±12.0 35.2±11.6

Height (cm) 158.7±7.7 164.0±6.6

Weight (kg) 76.2±16.2 80.2±10.7 2 2 BMI2 (kg/m2) 30.0±4.4 29.7±2.0

Waist circumference (cm) 96.4±12.0 99.0±8.1

Energy intake (kcal/d) 1997.0±35.6 2001.8±73.2

Calcium intake (mg/d) 320.2±93.7 328.2±87.7 1Each value represents the mean± SD. There were no significant differences between groups based on independent-samples t-test.

2BMI: Body Mass Index.

Physical characteristics and nutrient intake of study subjects.1

Table1:

Dietary Supplementation

20-22 23 All subjects were randomly divided into two singleblind groups: subjects in Hi-Ca group were provided Hi calcium drinks (calcium 300 mg/pack) every breakfast and dinner for eight weeks and prescribed a low-caloric diet providing 5.2 MJ/d (1200 kcal/d) during the intervention.

Experimental Design

For the control group, we provided only a low energy diet for eight weeks. The diets for the two groups were designed to provide comparable levels of macronutrients as follows: 55% carbohydrate, 20% protein, and 25% fat. Lectures about nutrition and weight management were provided to both groups on every visit. Anthropometric measurements were taken including height, weight, and the percentage of body fat during each weekly visit. Biochemical parameters were analyzed at beginning and end of the intervention. Dietary records and counseling were used to estimate dietary intake. We educated the participants about guidelines for 1200 kcal diets and gave instruction on protein sources and food portion sizes.

Analyses of Anthropometry and Serum Lipid Profiles

Anthropometry: Height, bodyweight, and waist circumference were measured, and the BMI was then calculated (screening, 0, 8 weeks). Body composition was measured using the In Body 3.0 Body Composition Analyzer. Systolic and diastolic blood pressures were measured in the right or the left arm Biochemical analysis: At screening, 0, and 8 weeks, blood samples were obtained following a twelve-hour fast and serum was stored at -80 °C until analysis. PTH level was determined using a commercial immunoradiometric assay. Cholesterol and triglyceride concentrations were determined enzymatically in plasma and lipoprotein fractions with an automatic immunoanalyzer. Plasma lipoprotein fractions (LDL and HDL) were isolated by ultracentrifugation.

Determination of Serum and Urinary Mineral Status

To monitor minerals in serum, the following laboratory parameters were determined at 0, 4, and 8 weeks: urinary calcium and serum calcium status. Serum calcium and urinary calcium were measured by the O-cresolphthalein complex colorimetric method using a Hitachi 7170S auto analyzer.

Assessment by Nutritional Survey

Nutrition was assessed from a 3-day diet record for two weekdays and one weekend day in weeks 0, 8, and information was collected on the day the subject returned. We mainly assessed the dietary intake of total energy, carbohydrates, protein, and fat to confirm that subjects did not change their eating habits. Dietary record data was measured by the Nutritional Chamberlain Line, Nutritionist Edition, version 2002, E-Kitchen Business Corp., Taiwan, which is referred to in the 1998 year database of the Department of Health, Taiwan.

Statistical Analysis

All data are expressed as the mean±SD. Differences between the beginning and end of treatment were tested by paired t-test. Differences between the Hi-Ca group and control group were tested with the independent-samples t-test. We used the

Figure 1
Figure 1. Experimental flow diagram.

to analyze all data. Simple Pearson correlations between calcium intakes were computed in the total sample of subjects as an indication of the relation between the degree of metabolic deterioration and calcium intake. A value of P<0.05 was used to indicate statistical significance.

Results

Anthropometric Characteristics and Dietary Intake

Baseline characteristics of participants are shown in Table 1. Baseline physical characteristics were similar in the Hi-Ca group and control group. All subjects were asked to keep regular physical activity and life style. Estimates of the energy, macronutrients, and calcium intake during the study period based on food records are shown in Table 2. These indicate no differences in energy, macronutrient, and fiber intake, and were very close to the recommended amounts of 55%, 20%, and 25%, respectively. After eight weeks, results showed that the calcium intake was 964.5±75.5 mg in the Hi-Ca group and was 353.7±96.6 mg in the control group (p<0.05).

As shown in Table 3, body weight, body mass index, body fat mass, body fat mass percentage, waist circumference and waist-hip ratio of the two groups decreased significantly after eight weeks of weight loss intervention (p<0.05 for all). Moreover, the loss of body weight (-6.9±3.3 kg, p<0.05), BMI (-2.7±1.1 kg/m2, p<0.01), body fat mass (-5.7±2.7 kg, p<0.05), body fat percentage (-4.4±1.9 %, p<0.002) in the Hi-Ca group differed significantly from those of control group after eight weeks.

Blood Glucose and Serum Lipids

As for lipid profiles, serum cholesterol, triglyceride and LDL-C concentration at Week 8 were significantly lower com- Weight (kg) 76.2±16.2 69.3±13.9 -6.9±3.3 80.2±10.7 75.1±9.5 -5.1±2.6 2 2 a BMI (kg/m ) 30.3 ±4.4 27.3±3.8 -2.7±1.1 29.7 ±2.0 27.8±1.8 -1.9±0.9 Body fat mass (kg) 28.7±7.3 23.0±5.6 -5.7±2.7 29.1±4.6 25.2±4.2 -3.9±1.4 Body fat percentage (%) 37.5±3.6 33.1±4.0 -4.4±1.9 36.5±5.1 33.8±5.2 -2.7±0.9 Muscle (kg) 44.2±9.4 43.5±9.4 -0.7±1.1 47.8±9.1 46.6±8.5 -1.2±1.3 3 a BMR (kcal) 1348.0±226.2 1321.8±215.5 -26.2±30.7 1500.4±231.3 1472.6±216.9 -27.8±29.9 Waist circumference (cm) 96.4±12.0 86.5±12.1 -9.9±4.2 99.0±8.1 88.0±6.9 -11.0±4.6 Waist-Hip ratio 0.96±0.06 0.91±0.05 -0.05±0.02 0.96±0.04 0.92±0.04 -0.04±0.02 Systolic pressure (mmHg) 125.3±12.7 118.8 ±8.8 -6.6±12.6 134.0±14.4 114.6±10.6 -19.5±17.3 Diastolic pressure (mmHg) 73.1±8.2 70.5±11.2 -1.1±7.9 83.1±9.4 73.4 ±7.8 -9.7±11.2 1Each value represents the mean ± SD.

2BMI: Body Mass Index 3BMR: Basal Metabolic Rate aThe Week 8 values are significantly different from Week 0, p<0.05. bValues are significantly different from control group, p<0.05. cValues are significantly different from Hi-Ca group, p<0.05. Anthropometric measurements before and after weight-loss intervention and change in variables between measurement periods1.

Table 3:

the Hi-Ca group than in the control group (p<0.05). There was no statistically significant difference in blood glucose levels and blood pressure between the two groups (Table 4).

Calcium Intake and Body Composition

The Hi-Ca group was significantly lower in serum PTH (parathyroid hormone) compared with baseline (-5.3±10.4 pg/ mL, p<0.05) at Week 0, which showed that the concentration of PTH and calcium intake were negatively correlated, indicating that using a high calcium low energy diet for weight loss produced more significant decrease in body weight, BMI, body fat mass, and body fat percentage. Significant negative correlations were observed between calcium intake changes and PTH levels, as shown in Table 5. (p<0.001).Significant negative correlations

week Hi Ca group Control group

0 1227.9±52.6 1224.5±63.4 Energy (kcal) 8 1232.4±68.4 1221.5±66.3 0 55.0±4.3 54.2±5.1 Carbohydrate percentage (%E) 8 55.2± 4.9 55.2±4.9 0 23.4±4.0 24.8±3.1 Fat percentage (%E) 8 23.5±5.3 24.2±3.0 0 19.3±1.9 19.2±2.0 Protein percentage (%E) 8 19.8±1.8 19.6±2.0 0 27.9±4.8 25.4±5.9 Dietary Fiber (g) 8 29.9±4.0 26.9±4.8 * 0 920.2±93.7 328.2±87.7 Calcium (mg) * 8 964.5±75.5 353.7±96.6 1Each value represents the mean±SD. There were no significant differences between groups based on independent-samples t-test.

%E, percentage of energy. *Values are significantly different with control group at Weeks 0 and 8, p<0.05.

Dietary intake of energy and macronutrients.1

Table 2:

Hi-Ca group Control group

Week 0 Week 8 Change Week 0 Week 8 Change a b a b a a a b a a b a a a a a a a a a a c a c

weight change (p<0.0001), body mass index (p<0.0001), body fat mass (p<0.0001), body fat mass percentage (p<0.001), and waist circumference (p<0.027).

Discussion

This study demonstrates that an energy restricted diet (1200 kcal/day) for eight weeks can lead to a significant reduction in weight, BMI, body fat mass and body fat percentage. Modest weight loss in obese individuals (5-10% of initial body weight) is likely to improve their health in the short term by re- 15,24 ducing the severity of comorbidities associated with obesity.

Our findings also indicate that a high calcium diet can lead to greater reduction in weight, BMI, body fat mass, and

2 a TG (mg/dL) 115.1±48.1 84.8±24.0 -20.6±53.6 127.7±60.1 109.2±58.3 -18.5±70.9 2 a TC (mg/dL) 183.1±24.5 157.2±25.3 -25.9±20.8 200.6±31.6 178.0 ±32.7 -22.6±22.0 2 a LDL-C (mg/dL) 115.2±21.9 97.4±20.7 -18.0±19.4 121.1±27.6 109.5±30.0 -11.6±17.4 2 a HDL-C (mg/dL) 40.9±12.9 37.6±9.9 -3.3±5.7 53.4±10.1 46.6±8.2 -6.8±6.6 TC/ HDL-C 4.8±1.2 4.4±1.0 -0.4±0.6 3.9±1.9 3.9±1.0 -0.1±0.6 Glucose (mg/dL) 102.3±20.1 96.7±11.4 -5.6 ±16.4 94.9±9.9 91.0±8.9 -3.8 ± 9.0 1Each value represents the mean±SD.

2TC: total cholesterol, TG: triglyceride, LDL-C: low density lipoprotein-cholesterol, HDL-C: high density lipoprotein-cholesterol. 3Glucose: fasting plasma glucose (normal range for Glucose=80-105 mg/dL) aThe Week 8 values are significantly different from Week 0, p<0.05. bValues are significantly different with control group, p<0.05. cValues are significantly different with Hi-Ca group, p<0.05 Serum lipid and glucose profiles before and after the weight-loss intervention and change in variables between measurement periods1.

Table 4:

energy-restricted diet on weight and fat loss (providing either 400-500 mg/day from dairy products, or 1200-1300 mg/day from an additional 800 mg of calcium carbonate, or from an additional three servings of dairy products) in 32 obese or overweight women. Their results indicated that increasing dietary calcium significantly augmented weight and fat loss secondary to caloric restriction.9

To date, numerous observational studies have identified a strong inverse relationship between body weight and dietary calcium and dairy product intake.25 A low calcium diet leads to an increase in 1,25(OH)2-D3, which in turn stimulates calcium influx into adipocytes, resulting in stimulation of adipocyte triglyceride stores. Suppressing 1,25(OH)2-D3 levels by increasing dietary calcium could thus be predicted to inhibit adiposity and promote weight loss. High dietary calcium intake is associated with reduced 1,25(OH)2-D3 levels which in turn act to decrease calcium influx into the cell. These modifications eventually stimulate lipolysis and inhibit lipogenesis in the adipo- 21,22,26 cytes. Increased intracellular calcium stimulates Fatty Acid Synthase (FAS), and inhibits lipolysis in adipocytes. Further, FAS is inhibited by calcium antagonism. Another mechanism that might explain the relationship of calcium consumption and adiposity is the effect of calcium on triglyceride absorption from the intestinal tract. Large amounts of calcium in the gastrointestinal tract may reduce absorption by precipitating insoluble fatty 18,30-33 acid calcium soaps.

The decrease in TC/HDL-C ratio observed in this study could be due to several effects attributed to calcium intake, such as a reduction in fatty acid absorption and increase in fecal fatty acid content, probably resulting from the formation of insoluble 18,30,31,34 calcium-fatty soaps in the gut. Other properties attributed to calcium are the mineral’s ability to bind bile acids, increase the conversion of cholesterol to bile acids, and thus increase 35,36 cholesterol excretion. In this regard, it has been shown that increasing dietary calcium suppresses the stimulation of calcium

Hi-Ca group Control group Week 0 Week 8 Change Week 0 Week 8 Change a

a

a a c a b

HDL-C levels significantly decreased compared with Week 0. The HDL-C levels are clinical findings commonly associated with smoking, visceral obesity, hypertriglyceridemia, use of certain drugs, and very low-fat diets.37

We did not observe a significant difference between groups in terms of a decrease in fasting plasma glucose and blood pressure in response to the intervention. Indeed, the Coronary Artery Risk Development in Young Adults Study showed that abnormal glucose homeostasis incidence decreased with in- 25 13 creasing dairy intake in overweight persons.13 Therefore, better understanding is still needed to determine whether the benefit of the calcium-induced improvement in glucose levels and blood pressure can be attributed to dairy products.

Consumption of a dairy calcium rich diet confers protection against loss of lean body mass during energy restriction (Hi-Ca group: -0.7±1.1 kg; Control group: -1.2±1.3 kg). This outcome may be attributable to the high proportion of BCAA (branched chain amino acid, including leucine, isolucine and 27,28 valine), found in dairy proteins. They play a specific metabolic 27-29 role as energy substrates and in the regulation of muscle protein 9,38-40 synthesis.

Low calcium intake increases PTH, resulting in increased cellular calcium. Supporting the role of PTH in obesity, a positive correlation between serum intact PTH and both BMI 10,41-43 and fat mass has been observed. In this study, negative correlations with PTH levels did reflect the differences in the Hi-Ca group (Hi-Ca group: -5.3±10.4 pg/mL; Control group: +11.5±14.3 pg/mL). Significant negative correlations were observed between PTH level and calcium intake changes. Significant negative correlations were likewise observed between calcium intake changes and body weight change, body mass index, body fat mass, body fat percentage, and waist circumference. For instance, in a study on 302 healthy volunteers, Parikh et al. found significantly lower plasma 1,25(OH)2-D3 levels in obese 16 44

shown to regulate adipocyte intracellular calcium, and it has been proposed as a potential mediator of the anti-obesity effect 46,47 of dietary calcium. In support of the role of PTH in obesity, positive correlations between serum PTH and BMI and fat mass have been reported by several studies.

In conclusion, we suggest that a high calcium diet increases the effectiveness of calorie-restriction for weight loss in overweight and obese people, while also improving cardiovascular disease risk profile. Further research could examine possible mechanisms on calcium and adipose tissue accumulation.

Strengths And Limitations

The strengths of this study include the objectively investigated the relationship between calcium intake and body composition, body fat distribution and serum lipid profile in overweight or obese subjects. We found a high calcium diet increases the effectiveness of an energy-restricted diet for weight loss in overweight people resulted in more significant decreases in body weight, BMI, body fat mass, and body fat percentage. However, physical activity were based on self-reported data, baseline physical characteristics were similar in the Hi-Ca group and control group. All subjects were asked to keep regular physical activity and life style. We did not tract physical activity during intervention. Future research could examine their physical activity levels during study.

Conflicts Of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

We would like to thank all subjects for participating in this study. This study was provided by grant SKH-TMU-99-12.

References

  1. SakhaeeKMaaloufNM. Dietary calcium, obesity and hypertension--the end of the road? J Clin Endocrinol Metab. 2005; 90: 4411-4413. doi: 10.1210/jc.2005-100410.1210/jc.2005-1004 https://doi.org/10.1210/jc.2005-1004
  2. McLaughlinTCarterSLamendolaC. Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults. Am J Clin Nutr. 2006; 84: 813-821
  3. BougouliaMTriantosAKoliakosG. Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women. Hormones (Athens). 2006; 5: 259-269
  4. Barbato KB, Martins Rde C, Rodrigues Mde L, Braga JU, Francischetti EA, Genelhu V. Effects of greater-than-5% weight 16,45 files of grade I obese subjects. Arq Bras Cardiol. 2006; 87: 12- 21. doi: 10.1590/S0066-782X2006001400003 https://doi.org/10.1590/s0066-782x2006001400003
  5. TeegardenD. Calcium intake and reduction in weight or fat 41-44,48 mass. J Nutr. 2003; 133: 249s-251s
  6. KumadaMKiharaSSumitsujiS. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003; 23: 85-89. doi: 10.1161/01. ATV.0000048856.22331.5010.1161/01.atv.0000048856.22331.50 https://doi.org/10.1161/01.atv.0000048856.22331.50
  7. WeyerCFunahashiTTanakaS. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001; 86: 1930-1935
  8. SelwynAP. Weight reduction and cardiovascular and metabolic disease prevention: clinical trial update. Am J Cardiol. 2007; 100: 33-37
  9. ZemelMBThompsonWMilsteadAMorrisKCampbellP. Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes Res. 2004; 12: 582-590
  10. ParikhSJYanovskiJA. Calcium intake and adiposity. Am J Clin Nutr. 2003; 77: 281-287
  11. ShaharDRAbelRElhayanyAVardiHFraserD. Does dairy calcium intake enhance weight loss among overweight diabetic patients? Diabetes Care. 2007; 30: 485-489. doi: 10.2337/ dc06-1564
  12. ZemelMB. Role of calcium and dairy products in energy partitioning and weight management. Am J Clin Nutr. 2004; 79: 907-912
  13. Pereira MA, Jacobs DR, Jr., Van Horn L, Slattery ML, Kartashov AI, Ludwig DS. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. JAMA. 2002; 287: 2081-2089. doi: 10.1001/jama.287.16.2081 https://doi.org/10.1001/jama.287.16.2081
  14. KnowlerWCBarrett-ConnorEFowlerSE. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346: 393-403. doi: 10.1056/ NEJMoa012512
  15. ZemelMBRichardsJMilsteadACampbellP. Effects of calcium and dairy on body composition and weight loss in African-American adults. Obes Res. 2005; 13: 1218-1225
  16. ZemelMBShiHGreerBDirienzoDZemelPC. Regulation of adiposity by dietary calcium. FASEB J. 2000; 14: 1132- 1138
  17. McCarronDAMorrisCDHenryHJStantonJL. Blood 224: 1392-1398. doi: 10.1126/science.672945910.1126/science.6729459 https://doi.org/10.1126/science.6729459
  18. DenkeMASemposCTGrundySM. Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men. Arch Intern Med. 1993; 153: 1093- 1103. doi: 10.1001/archinte.1993.0041009004500610.1001/archinte.1993.00410090045006 https://doi.org/10.1001/archinte.1993.00410090045006
  19. ShapsesSAHeshkaSHeymsfieldSB. Effect of calcium supplementation on weight and fat loss in women. J Clin Endocrinol Metab. 2004; 89: 632-637. doi: 10.1210/jc.2002-02113610.1210/jc.2002-021136 https://doi.org/10.1210/jc.2002-021136
  20. BarrSI. Increased dairy product or calcium intake: is body weight or composition affected in humans? J Nutr. 2003; 133: 245s-248s
  21. BarbaGRussoP. Dairy foods, dietary calcium and obesity: a short review of the evidence. Nutr Metab Cardiovasc Dis. 2006; 16: 445-451
  22. ZemelMB. The role of dairy foods in weight management. J Am Coll Nutr. 2005; 24: 537s-546s
  23. TeegardenDZemelMB. Dairy product components and weight regulation: symposium overview. J Nutr. 2003; 133: 243s-244s
  24. DrewBSDixonAFDixonJB. Obesity management: update on orlistat. Vasc Health Risk Manag. 2007; 3: 817-821
  25. HuthPJDiRienzoDBMillerGD. Major scientific advances with dairy foods in nutrition and health. J Dairy Sci. 2006; 89: 1207-1221. doi: 10.3168/jds.S0022-0302(06)72190-710.3168/jds.s0022-0302(06)72190-7 https://doi.org/10.3168/jds.s0022-0302(06)72190-7
  26. Thompson WG, Rostad Holdman N, Janzow DJ, Slezak JM, Morris KL, Zemel MB. Effect of energy-reduced diets high in dairy products and fiber on weight loss in obese adults. Obes Res. 2005; 13: 1344-1353
  27. XueBGreenbergAGKraemerFBZemelMB. Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes. FASEB J. 2001; 15: 2527-2579
  28. XueBMoustaidNWilkisonWOZemelMB. The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+dependent mechanism. FASEB J. 1998; 12: 1391-1396
  29. KimJHMynattRLMooreJWWoychikRPMoustaidNZemelMB. The effects of calcium channel blockade on agoutiinduced obesity. FASEB J. 1996; 10: 1646-1652
  30. VaskonenT. Dietary minerals and modification of cardiovascular risk factors. J Nutr Biochem. 2003; 14: 492-506. doi: 10.1016/S0955-2863(03)00074-310.1016/s0955-2863(03)00074-3 https://doi.org/10.1016/s0955-2863(03)00074-3
  31. Devraj R, Williams HD, Warren DB, Mullertz A, Porter CJ, systems: calcium ions combine with fatty acids liberated from triglyceride rich lipid solutions to form soaps and reduce the solubilization capacity of colloidal digestion products. Int J Pharm. 2013; 441: 323-333. doi: 10.1016/j.ijpharm.2012.11.024 https://doi.org/10.1016/j.ijpharm.2012.11.024
  32. ChristensenRLorenzenJKSvithCR. Effect of calcium from dairy and dietary supplements on faecal fat excretion: a meta-analysis of randomized controlled trials. Obes Rev. 2009; 10: 475-486. doi: 10.1111/j.1467-789X.2009.00599.x10.1111/j.1467-789x.2009.00599.x https://doi.org/10.1111/j.1467-789x.2009.00599.x
  33. BuchowskiMSAslamMDossettCDorminyCChoiLAcraS. Effect of dairy and non-dairy calcium on fecal fat excretion in lactose digester and maldigester obese adults. Int J Obes (Lond). 2010; 34: 127-135. doi: 10.1038/ijo.2009.21210.1038/ijo.2009.212 https://doi.org/10.1038/ijo.2009.212
  34. ReidIR. Effects of calcium supplementation on circulating lipids: potential pharmacoeconomic implications. Drugs Aging. 2004; 21: 7-17
  35. SaundersDSilleryJChapmanR. Effect of calcium carbonate and aluminum hydroxide on human intestinal function. Dig Dis Sci. 1988; 33: 409-413
  36. Van der MeerRWelbergJWKuipersF. Effects of supplemental dietary calcium on the intestinal association of calcium, phosphate, and bile acids. Gastroenterology. 1990; 99: 1653-1659
  37. FortiNDiamentJ. High-density lipoproteins: metabolic, clinical, epidemiological and therapeutic intervention aspects. An update for clinicians. Arq Bras Cardiol.2006; 87: 671-679
  38. LaymanDKBoileauRAEricksonDJ. A reduced ratio of dietary carbohydrate to protein improves body composition and blood lipid profiles during weight loss in adult women. J Nutr. 2003; 133: 411-417
  39. JosseARAtkinsonSATarnopolskyMAPhillipsSM. Increased consumption of dairy foods and protein during diet- and exercise-induced weight loss promotes fat mass loss and lean mass gain in overweight and obese premenopausal women. J Nutr. 2011; 141: 1626-1634. doi: 10.3945/jn.111.14102810.3945/jn.111.141028 https://doi.org/10.3945/jn.111.141028
  40. McGregorRAPoppittSD. Milk protein for improved metabolic health: a review of the evidence. Nutr Metab (Lond). 2013; 10: 46. doi: 10.1186/1743-7075-10-4610.1186/1743-7075-10-46 https://doi.org/10.1186/1743-7075-10-46
  41. AlemzadehRKichlerJ. Parathyroid hormone is associated with biomarkers of insulin resistance and inflammation, independent of vitamin D status, in obese adolescents. Metab Syndr Relat Disord. 2012; 10: 422-429
  42. IshimuraEOkunoSTsuboniwaN. Significant positive association between parathyroid hormone and fat mass and lean mass in chronic hemodialysis patients. J Clin Endocrinol
  43. KamychevaESundsfjordJJordeR. Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study. Eur J Endocrinol. 2004; 151: 167-172
  44. ParikhSJEdelmanMUwaifoGI. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004; 89: 1196-1199. doi: 10.1210/jc.2003-03139810.1210/jc.2003-031398 https://doi.org/10.1210/jc.2003-031398
  45. NiZSmogorzewskiMMassrySG. Effects of parathyroid hormone on cytosolic calcium of rat adipocytes. Endocrinology. 1994; 135: 1837-1844. doi: 10.1210/endo.135.5.752525410.1210/endo.135.5.7525254 https://doi.org/10.1210/endo.135.5.7525254
  46. GuntherCWLyleRMLegowskiPA. Fat oxidation and its relation to serum parathyroid hormone in young women enrolled in a 1-y dairy calcium intervention. Am J Clin Nutr. 2005; 82: 1228-1234
  47. TeegardenD. The influence of dairy product consumption on body composition. J Nutr. 2005; 135: 2749-2752
  48. SnijderMBvan DamRMVisserM. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab. 2005; 90: 4119-4123. doi: 10.1210/jc.2005-021610.1210/jc.2005-0216 https://doi.org/10.1210/jc.2005-0216